Following a decision by China Food and Drug Administration in February 2014 to regulate genetic testing, BGI has anounced to suspend prenatal testing but continue to use the test after birth. BGI is now in the process of product registration according to CFDA provisions
BGI news release, March 13, 2014
BGI suspends non-invasive fetal trisomy test in Mainland China